Prozac Patent Challenge Trial To Last Two Weeks After Rulings Reduce Scope
Executive Summary
The patent challenge trial for Eli Lilly's Prozac is expected to run for two weeks after pre-trial rulings limited the issues Barr could bring against Lilly.